scholarly journals Pre-Operative Moderate to Severe Chronic Kidney Disease is Associated with Worse Short-Term and Mid-Term Outcomes in Patients Undergoing Fenestrated-Branched Endovascular Aortic Repair

2021 ◽  
Author(s):  
Mario D’Oria ◽  
Anders Wanhainen ◽  
David Lindström ◽  
Gustaf Tegler ◽  
Kevin Mani
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Endovascular Aortic Repair ◽  
Short Term ◽  
Aortic Repair ◽  
Severe Chronic Kidney Disease

Fenestrated-branched endovascular aortic repair in patients with chronic kidney disease

2020 ◽  
Vol 72 (1) ◽  
pp. 66-72 ◽  
Author(s):  
Mitri K. Khoury ◽  
David E. Timaran ◽  
Marilisa Soto-Gonzalez ◽  
Carlos H. Timaran
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Endovascular Aortic Repair ◽  
Aortic Repair

scholarly journals Outcomes after thoracic endovascular aortic repair in patients with chronic kidney disease in the Medicare population

2020 ◽  
Vol 159 (2) ◽  
pp. 402-413 ◽  
Author(s):  
Chase R. Brown ◽  
Zehang Chen ◽  
Fabliha Khurshan ◽  
Maximillian Kreibich ◽  
Joseph Bavaria ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Thoracic Endovascular Aortic Repair ◽  
Endovascular Aortic Repair ◽  
Medicare Population ◽  
Aortic Repair

scholarly journals Fenestrated/Branched Endovascular Aortic Repair in Patients With Chronic Kidney Disease

2019 ◽  
Vol 69 (1) ◽  
pp. e11
Author(s):  
Mitri Khoury ◽  
David Timaran-Montenegro ◽  
Marilisa Soto-Gonzalez ◽  
Carlos Timaran
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Endovascular Aortic Repair ◽  
Aortic Repair

scholarly journals Thoracic Endovascular Aortic Repair for Aortic Aneurysm Is Safe in Patients With Chronic Kidney Disease, but at a Cost

2020 ◽  
Vol 72 (1) ◽  
pp. e104
Author(s):  
Alexander S. Kim ◽  
Joel L. Ramirez ◽  
Elizabeth M. Lancaster ◽  
Devin Zarkowsky ◽  
Virendra I. Patel ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Aortic Aneurysm ◽  
Thoracic Endovascular Aortic Repair ◽  
Endovascular Aortic Repair ◽  
Aortic Repair

Lesser eGFR Decline with Dulaglutide Regardless of Weight Changes in People with Type 2 Diabetes and Moderate to Severe Chronic Kidney Disease (AWARD-7)

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1066-P ◽  
Author(s):  
KATHERINE R. TUTTLE ◽  
MARK LAKSHMANAN ◽  
BRIAN L. RAYNER ◽  
ROBERT S. BUSCH ◽  
ALAN G. ZIMMERMANN ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Weight Changes ◽  
Severe Chronic Kidney Disease ◽  
Egfr Decline

A PILOT STUDY: PLASMA GALECTIN-3 LEVEL IN HEART FAILURE PATIENTS

2017 ◽  
pp. 101-106
Author(s):  
Thi Thanh Hien Bui ◽  
Hieu Nhan Dinh ◽  
Anh Tien Hoang
Keyword(s):  
Heart Failure ◽  
Chronic Kidney Disease ◽  
Acute Coronary Syndrome ◽  
Kidney Disease ◽  
Heart Failure Patients ◽  
Coronary Syndrome ◽  
Nyha Classification ◽  
Galectin 3 ◽  
Severe Chronic Kidney Disease ◽  
Esc Guidelines

Background: Despite of considerable advances in its diagnosis and management, heart failure remains an unsettled problem and life threatening. Heart failure with a growing prevalence represents a burden to healthcare system, responsible for deterioration of patient’s daily activities. Galectin-3 is a new cardiac biomarker in prognosis for heart failure. Serum galectin-3 has some relation to heart failure NYHA classification, acute coronary syndrome and clinical outcome. Level of serum galectin-3 give information for prognosis and help risk stratifications in patient with heart failure, so intensive therapeutics can be approached to patients with high risk. Objective: To examine plasma galectin-3 level in hospitalized heart failure patients, investigate the relationship between galectin-3 level with associated diseases, clinical conditions and disease progression in hospital. Methodology: Cross sectional study. Result: 20 patients with severe heart failure as NYHA classification were diagnosed by The ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2012) and performed blood test for serum galectin-3 level. Increasing of serum galectin-3 level have seen in all patients, mean value is 36.5 (13.7 – 74.0), especially high level in patient with acute coronary syndrome and patients with severe chronic kidney disease. There are five patients dead. Conclusion: Serum galectin-3 level increase in patients with heart failure and has some relation to NYHA classification, acute coronary syndrome. However, level of serum galectin-3 can be affected by severe chronic kidney disease, more research is needed on this aspect Key words: Serum galectin-3, heart failure, ESC Guidelines, NYHA

Sign in / Sign up

Export Citation Format

Share Document